Andreas Halvorsen: portfolio of Viking Global Investors
Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.
Source: 13F filing with the US Securities and Exchange Commission dated Feb 14, 2024. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q4 2023. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 27.3B USD
- Positions
- 78
- Share of the ten largest
- 40.2%
The ten largest positions Q4 2023
- Visa Inc. 5.4%▼ −18.4%
- United Parcel Service 4.7%▲ +23.1%
- Api Group Corp 4.4%▲ +0.3%
- Workday, Inc. 4.2%▼ −21.6%
- Meta Platforms 3.9%▼ −2.1%
- McKesson Corporation 3.8%▲ +53.2%
- Bridgebio Pharma Inc 3.7%unchanged
- Progressive Corporation 3.4%▲ +412.0%
- Danaher Corporation 3.4%▼ −2.6%
- Philip Morris International 3.3%▲ +61.2%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q4 2023
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| AMZN Amazon | 2.7% | 4,929,649 | 749.0M USD | −43.7% reduced | Q2 2015 35 quarters |
| V Visa Inc. | 5.4% | 5,690,106 | 1.5B USD | −18.4% reduced | Q3 2016 30 quarters |
| Bridgebio Pharma Inc | 3.7% | 25,120,991 | 1.0B USD | unchanged | Q2 2019 19 quarters |
| Adaptive Biotechnologies Cor | 0.5% | 29,993,708 | 147.0M USD | unchanged | Q2 2019 19 quarters |
| FTV Fortive | 2.8% | 10,525,824 | 775.0M USD | +26.4% increased | Q3 2019 18 quarters |
| Api Group Corp | 4.4% | 34,302,815 | 1.2B USD | +0.3% increased | Q2 2020 15 quarters |
| TMO Thermo Fisher Scientific | 1.0% | 538,485 | 285.8M USD | −40.1% reduced | Q2 2020 15 quarters |
| Royalty Pharma PLC | 1.0% | 10,087,417 | 283.4M USD | +6.6% increased | Q2 2020 15 quarters |
| Inhibrx Inc | 1.0% | 7,150,826 | 271.7M USD | unchanged | Q3 2020 14 quarters |
| META Meta Platforms | 3.9% | 2,991,633 | 1.1B USD | −2.1% reduced | Q4 2020 13 quarters |
| GE GE Aerospace | 2.4% | 5,086,398 | 649.2M USD | −36.4% reduced | Q4 2020 13 quarters |
| Acadia Healthcare Company In | 0.8% | 2,800,350 | 217.8M USD | +24.2% increased | Q4 2020 13 quarters |
| 4D Molecular Therapeutics In | 0.4% | 4,787,914 | 97.0M USD | unchanged | Q4 2020 13 quarters |
| Kinnate Biopharma Inc | < 0.1% | 1,820,462 | 4.3M USD | unchanged | Q4 2020 13 quarters |
| AMP Ameriprise Financial | 2.7% | 1,914,374 | 727.1M USD | +10.4% increased | Q1 2021 12 quarters |
| Pharvaris N V | 0.4% | 3,656,923 | 102.6M USD | +13.2% increased | Q1 2021 12 quarters |
| Edgewise Therapeutics Inc | 0.2% | 6,159,146 | 67.4M USD | unchanged | Q1 2021 12 quarters |
| Zai Lab Ltd | 0.2% | 1,869,283 | 51.1M USD | −25.0% reduced | Q1 2021 12 quarters |
| Day One Biopharmaceuticals I | 0.1% | 2,558,563 | 37.4M USD | unchanged | Q2 2021 11 quarters |
| Hdfc Bank Ltd | 2.4% | 9,740,785 | 653.7M USD | −3.7% reduced | Q3 2021 10 quarters |
| Ginkgo Bioworks Holdings Inc | 0.9% | 143,085,126 | 241.8M USD | unchanged | Q3 2021 10 quarters |
| Rallybio Corp | < 0.1% | 4,194,777 | 10.0M USD | unchanged | Q3 2021 10 quarters |
| Roivant Sciences Ltd | 2.9% | 69,368,961 | 779.0M USD | −5.5% reduced | Q4 2021 9 quarters |
| Biomarin Pharmaceutical Inc | 1.7% | 4,889,454 | 471.4M USD | +16.0% increased | Q4 2021 9 quarters |
| IFF International Flavors & Fragrances | 0.3% | 953,384 | 77.2M USD | −53.9% reduced | Q4 2021 9 quarters |
| Lianbio | < 0.1% | 3,564,173 | 15.9M USD | unchanged | Q4 2021 9 quarters |
| PGR Progressive Corporation | 3.4% | 5,863,559 | 933.9M USD | +412.0% increased | Q1 2022 8 quarters |
| MA Mastercard | 1.8% | 1,157,231 | 493.6M USD | +295.9% increased | Q1 2022 8 quarters |
| Amylyx Pharmaceuticals Inc | 0.2% | 2,962,555 | 43.6M USD | unchanged | Q1 2022 8 quarters |
| MCK McKesson Corporation | 3.8% | 2,233,205 | 1.0B USD | +53.2% increased | Q2 2022 7 quarters |
| Pepgen Inc | < 0.1% | 1,482,434 | 10.1M USD | unchanged | Q2 2022 7 quarters |
| UNH UnitedHealth Group | 0.9% | 460,782 | 242.6M USD | −75.2% reduced | Q3 2022 6 quarters |
| Valvoline Inc | 0.4% | 3,176,309 | 119.4M USD | −64.2% reduced | Q3 2022 6 quarters |
| CDNS Cadence Design Systems | 0.2% | 228,482 | 62.2M USD | −86.2% reduced | Q3 2022 6 quarters |
| Trevi Therapeutics Inc | < 0.1% | 4,400,000 | 5.9M USD | unchanged | Q3 2022 6 quarters |
| Kbr Inc | 0.5% | 2,633,844 | 145.9M USD | +69.4% increased | Q4 2022 5 quarters |
| CSX CSX Corporation | 0.4% | 3,133,913 | 108.7M USD | −70.5% reduced | Q4 2022 5 quarters |
| Newamsterdam Pharma Company | 0.3% | 8,024,565 | 89.6M USD | unchanged | Q4 2022 5 quarters |
| WDAY Workday, Inc. | 4.2% | 4,106,723 | 1.1B USD | −21.6% reduced | Q1 2023 4 quarters |
| Coupang Inc | 0.9% | 15,494,869 | 250.9M USD | +255.2% increased | Q1 2023 4 quarters |
| Cnh Indl N V | 0.4% | 9,856,276 | 120.0M USD | +46.2% increased | Q1 2023 4 quarters |
| Viking Therapeutics Inc | 0.4% | 5,145,112 | 95.8M USD | +12.5% increased | Q1 2023 4 quarters |
| UPS United Parcel Service | 4.7% | 8,199,127 | 1.3B USD | +23.1% increased | Q2 2023 3 quarters |
| DHR Danaher Corporation | 3.4% | 4,004,517 | 926.4M USD | −2.6% reduced | Q2 2023 3 quarters |
| PM Philip Morris International | 3.3% | 9,623,947 | 905.4M USD | +61.2% increased | Q2 2023 3 quarters |
| CBRE CBRE Group | 1.3% | 3,809,555 | 354.6M USD | +52.1% increased | Q2 2023 3 quarters |
| DASH DoorDash | 1.3% | 3,489,066 | 345.0M USD | −35.0% reduced | Q2 2023 3 quarters |
| EG Everest Group | 0.8% | 652,302 | 230.6M USD | −19.3% reduced | Q2 2023 3 quarters |
| FIVE9 Inc | 0.8% | 2,714,117 | 213.6M USD | −24.5% reduced | Q2 2023 3 quarters |
| PPG PPG Industries | 0.5% | 968,866 | 144.9M USD | −76.0% reduced | Q2 2023 3 quarters |
| Epam Sys Inc | 0.4% | 368,708 | 109.6M USD | −59.9% reduced | Q2 2023 3 quarters |
| Verastem Inc | < 0.1% | 2,456,292 | 20.0M USD | unchanged | Q2 2023 3 quarters |
| FCX Freeport-McMoRan | 1.7% | 11,053,254 | 470.5M USD | +13.1% increased | Q3 2023 2 quarters |
| Rayzebio Inc | 1.5% | 6,642,700 | 413.0M USD | unchanged | Q3 2023 2 quarters |
| MET MetLife | 1.4% | 5,616,556 | 371.4M USD | +91.5% increased | Q3 2023 2 quarters |
| ISRG Intuitive Surgical | 1.2% | 931,484 | 314.2M USD | +45.3% increased | Q3 2023 2 quarters |
| BSX Boston Scientific | 0.5% | 2,267,761 | 131.1M USD | +104.2% increased | Q3 2023 2 quarters |
| KDP Keurig Dr Pepper | 0.4% | 2,886,871 | 96.2M USD | +26.2% increased | Q3 2023 2 quarters |
| BEKE KE Holdings | 0.3% | 5,285,000 | 85.7M USD | +14.4% increased | Q3 2023 2 quarters |
| Foot Locker Inc | 0.1% | 1,073,749 | 33.4M USD | – | Q3 2023 2 quarters |
| AMD Advanced Micro Devices | 2.6% | 4,737,399 | 698.3M USD | new | Q4 2023 1 quarter |
| DE Deere & Company | 2.1% | 1,406,562 | 562.4M USD | new | Q4 2023 1 quarter |
| GOOGL Alphabet Inc. (Class A) | 1.7% | 3,293,461 | 460.1M USD | new | Q4 2023 1 quarter |
| Cboe Global Mkts Inc | 1.6% | 2,412,499 | 430.8M USD | new | Q4 2023 1 quarter |
| USB U.S. Bancorp | 1.5% | 9,569,638 | 414.2M USD | new | Q4 2023 1 quarter |
| TTWO Take-Two Interactive | 1.4% | 2,412,234 | 388.2M USD | new | Q4 2023 1 quarter |
| Lamb Weston HLDGS Inc | 1.4% | 3,545,376 | 383.2M USD | new | Q4 2023 1 quarter |
| TMUS T-Mobile US | 0.9% | 1,509,999 | 242.1M USD | new | Q4 2023 1 quarter |
| HCA HCA Healthcare | 0.7% | 725,216 | 196.3M USD | new | Q4 2023 1 quarter |
| KKR KKR & Co. | 0.4% | 1,388,521 | 115.0M USD | new | Q4 2023 1 quarter |
| VEEV Veeva Systems | 0.4% | 579,753 | 111.6M USD | new | Q4 2023 1 quarter |
| TEAM Atlassian | 0.4% | 435,946 | 103.7M USD | new | Q4 2023 1 quarter |
| Regal Rexnord Corporation | 0.4% | 691,717 | 102.4M USD | new | Q4 2023 1 quarter |
| LLY Lilly (Eli) | 0.3% | 138,728 | 80.9M USD | new | Q4 2023 1 quarter |
| SYK Stryker Corporation | 0.3% | 248,913 | 74.5M USD | new | Q4 2023 1 quarter |
| MRSH Marsh McLennan | 0.2% | 237,706 | 45.0M USD | new | Q4 2023 1 quarter |
| Procore Technologies Inc | 0.2% | 613,437 | 42.5M USD | new | Q4 2023 1 quarter |
| Cazoo Group Ltd | < 0.1% | 2,142,728 | 20.4M USD | new | Q4 2023 1 quarter |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Plus 1 position in convertible bonds and bonds worth 28.9M USD as reported – not included in the weights.
Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.
- Guardant Health Inc principal 41.0M USD 28.9M USD
Breakdown by sector
- Financials 17.6%
- Health Care 12.5%
- Industrials 12.4%
- Communication Services 7.9%
- Technology 6.9%
- Consumer Discretionary 4.0%
- Consumer Staples 3.7%
- Materials 2.5%
- Real Estate 1.3%
- not in our coverage 31.1%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors